Achromatopsia (ACHM) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition: AchromatopsiaIntervention: Drug: rAAV.hCNGA3Sponsors: STZ eyetrial; University Hospital TuebingenRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials
Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition: AchromatopsiaIntervention: Drug: rAAV.hCNGA3Sponsors: STZ eyetrial; University Hospital Tuebingen; Ludwig-Maximilians - University of MunichRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials
Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition: AchromatopsiaIntervention: Drug: rAAV.hCNGA3Sponsors: STZ eyetrial; University Hospital TuebingenRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials
Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia
Condition: AchromatopsiaIntervention: Drug: rAAV.hCNGA3Sponsors: STZ eyetrial; University Hospital Tuebingen; Ludwig-Maximilians - University of MunichRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2015 Category: Research Source Type: clinical trials